Comparative Effect of Sahrmann's Exercises and Core Stabilization Exercises on Low Back Pain in Individuals With Lumbar Lordosis

May 6, 2026 updated by: Fatima Zainab, Rashid Latif Medical College
Comparative effect of Sahrmann's exercises and core stabilization exercises on low back pain in individuals with lumbar lordosis

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Low Back pain is the most usual cause of disability and is worsening on a global scale. The prevalence of Low back pain is reported to be about 80%. Lumbar lordosis has significance because of its distinctive position and its direct contact with the pelvis. Increased lordosis leads to excessive compression of apophyseal joint. Sahrmann's exercises refers to address the muscular component by shortening long muscles, reducing the load on weak or long muscles, supporting weakened using specific muscles to train the patient to activate specific muscles in a precise manner, and emphasize correct use of muscles in postural positioning activity and functional activity. The commonly used core stability training programs is the McGill Big 3 core stability exercise which was introduced by McGill and Karpowicz. Core stability has an impressive effect even on prevention of low back and lumbar lordosis. Core stability training has been widely used in physical therapy as treatment of low back pain.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
72

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • Arif Memorial Teaching Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Male and Female patients
  • Age 20-60
  • Low back pain
  • Functional disability

Exclusion Criteria:

  • Pathological signs, Ankle injury, pregnant females, previous surgery
  • History of any specific medication
  • Regular high intensity exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Sahrmann's Exercises
Sahrmann's exercises refers to address the muscular component by shortening long muscles, reducing the load on weak or long muscles, supporting weakened using specific muscles to train the patient to activate specific muscles in a precise manner, and emphasize correct use of muscles in postural positioning activity and functional activity. Sahrmann's approach is based on biomechanical view and contains stretching and strengthening exercises.
Other: Sahrmann's Exercises
Sahrmann's Exercises include exercises like Pelvic Clock which strengthen transverse abdominis and improve pelvic alignment. Its positions includes; Pelvic tilt (12 o'clock), Lateral pelvic shift (3 o'clock and 9 o'clock), Posterior pelvic tilt (6 o'clock) with 3 sets of 10-15 repetitions. Lumbar Extensions which enhance lumbar lordosis and strengthen erector spinae. Bridging which strengthen gluteus maximus and improve hip-pelvic alignment. Knee to Chest stretch which improves lumbar flexibility, mobility, enhances strength of hip and pelvic muscles.
Other Names:
  • Exercise
Active Comparator: Core Stabilization Exercises
The point of core stability exercises is to provide normal muscle function to increase spinal stability. The commonly used core stability training programs is the McGill Big 3 core stability exercise which was introduced by McGill and Karpowicz. Its main focus is on the influence of trunk stability on low back pain and lordosis. Core stability training re-educates the postural core muscles to stabilize the lumbopelvic region.
Other: Core Stabilization Exercises
Core Stabilization Exercises includes; Curl-Up which strengthen the rectus abdominis and transverse abdominis muscles with 3 sets of 10-15 repetitions. Bird Dog which strengthen the extensor muscles, including the erector spinae and latissimus dorsi. Side Plank (Modified Plank) which strengthen the transverse abdominis and oblique muscles.
Other Names:
  • Exercise

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Pain Intensity
Time Frame: Baseline and 4th week
The intensity of pain was measured by a numerical pain rating scale is an accurate and reliable tool for measuring pain intensity. It is a scale rating from 0 to 10 (no pain to moderate pain and to severe pain).
Baseline and 4th week

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Disability
Time Frame: Baseline and 4th week
Disability was measured by Oswestry disability index is a questionnaire includes total 10 sections and each section has 5 further statements related daily routine activities e.g. lifting, washing, walking, traveling, sitting etc. The possible score is 5 for each section. The score ranges from 0 (minimum disability) to 50 (maximum disability) indicating disability index.
Baseline and 4th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Rashid Latif Medical College

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • LAURIN, E., MINERBI, A., BESEMANN, L. M., COURCHESNE, C. I. & GUPTA, G. 2022. The McGill Approach to Core Stabilization in the Treatment of Chronic Low Back Pain: A Review. medRxiv, 2022.01. 21.22269311.
  • NIROOMAND, T., RABIEI, M. & MOHAMMADI, B. 2023. Investigating the Effects Janda's and Sahrmann's Correcting Exercise Approaches on Trunk Muscles Function in Young Girls with Lower Crossed Syndrome. Journal of Advanced Sport Technology, 7, 48-58.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 10, 2024

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
January 20, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
January 20, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 27, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 27, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 4, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 11, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 6, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • IRB/2024/160

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The data will be shared on request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Sahrmann's Exercises

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings